martes, 1 de octubre de 2013

National Guideline Clearinghouse | Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease.

full-text ►
National Guideline Clearinghouse | Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease.

 National Institute for Health and Care Excellence (NICE)
National Guideline Clearinghouse (NGC)

September 30, 2013


Guideline Title
Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease.
 
Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease. London (UK): National Institute for Health and Clinical Excellence (NICE); 2013 Mar. 22 p. (Clinical guideline; no. 157). 
 
Guideline Status
This is the current release of the guideline.

No hay comentarios:

Publicar un comentario